Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia
Open Access
- 1 August 2010
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (35) , 26861-26868
- https://doi.org/10.1074/jbc.m110.134023
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- FoxO1 Controls Insulin-dependent Adipose Triglyceride Lipase (ATGL) Expression and Lipolysis in AdipocytesJournal of Biological Chemistry, 2009
- Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth RegulationPublished by Elsevier ,2008
- The Double Life of IrsCell Metabolism, 2008
- Hepatic insulin resistance directly promotes formation of cholesterol gallstonesNature Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesNew England Journal of Medicine, 2008
- Selective versus Total Insulin Resistance: A Pathogenic ParadoxPublished by Elsevier ,2008
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21Published by Elsevier ,2007
- Diminished Hepatic Gluconeogenesis via Defects in Tricarboxylic Acid Cycle Flux in Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α)-deficient MiceJournal of Biological Chemistry, 2006
- Protein Sensors for Membrane SterolsCell, 2006
- Diminished Hepatic Response to Fasting/Refeeding and Liver X Receptor Agonists in Mice with Selective Deficiency of Sterol Regulatory Element-binding Protein-1cJournal of Biological Chemistry, 2002